ITIH2 Antikörper (Cleaved-Asp702)

Produktnummer ABIN1452255

Produktdetails anti-ITIH2 Antikörper

Target: ITIH2 (Inter-alpha Globulin Inhibitor H2 Polypeptide (ITIH2))

Bindungsspezifität: AA 653-702, Cleaved-Asp702

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ITIH2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Spezifität:

ITIH2 (Cleaved-Asp702) Antibody detects endogenous levels of fragment of activated ITIH2 resulting from cleavage adjacent to Asp702.

Aufreinigung: The antibody was purified from rabbit antiserum by affinity-chromatography using immunogen.

Immunogen: The antiserum was produced against synthesized peptide derived from human ITIH2.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB: 1:500~1:1000 ELISA: 1:10000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Stable at -20°C for at least 1 year.

Details zu ITIH2

Target: ITIH2 (Inter-alpha Globulin Inhibitor H2 Polypeptide (ITIH2))

Andere Bezeichnung: ITIH2 (ITIH2 Produkte)

Synonyme: AI747202 antikoerper, Intin2 antikoerper, Itih-2 antikoerper, H2P antikoerper, SHAP antikoerper, ITI-HC2 antikoerper, inter-alpha trypsin inhibitor, heavy chain 2 antikoerper, inter-alpha-trypsin inhibitor heavy chain 2 antikoerper, Itih2 antikoerper, ITIH2 antikoerper

Hintergrund:

Synonyms: Inter-alpha-trypsin inhibitor heavy chain H2, Inter-alpha-inhibitor heavy chain 2, ITI heavy chain H2, Inter-alpha-trypsin inhibitor complex component II, Serum-derived hyaluronan-associated protein, SHAP, IGHEP2

NCBI Gene Symbol: ITIH2

Molekulargewicht: 106 kDa

Gen-ID: 3698

OMIM: 146640

UniProt: P19823

Pathways: Glycosaminoglycan Metabolic Process